HIV pharmacology/med chem Flashcards
HIV has what kind of nucleic acid structure
ssRNS with reverse transcriptase
CD4 role in HIV life cycle
CD4 is on surface of T cells/macrophage and the HIV virion attaches to CD4, allowing entrance into the cell
sequence of events in HIV life cycle
- fusion of HIV to host cell
- RNA, RT, integrase, and proteins enter
- viral DNA is formed by RT
- DNA is integrated with host DNA
- new viral RNA is made, and viral proteins come as result
- viral RNA and proteins moves to surface
- virus is released and protease makes mature proteins
classes of HIV drugs
- NRTIs
- NNRTIs
- protease inhibitors
- integrase inhibitors
- entry inhibitors
NRTIs MoA
replace DNA/RNa components, but lack 3’ OH so they terminate the elongation chain
NRTI resistance
associated with mutations in pol gene that encodes for RT
NRTI adverse effects
mitochondrial toxicity leading to:
- neuropathy
- myopathy
- hepatic steatosis with lactic acidosis
NRTI drugs
zidovudine*not as important* lamivudine abacavir tenofovir emtricitabine
zidovudine features
very short half life so dosing is 2-6 times per day
lamivudine features
- once daily dosing
- can reverse zidovudine resistance
- renal dosing is very important
emtricitabine features
more potent than lamivudine with less severe side effects
tenofovir features
- nucleoTIDE analog, not nucleoside
- prodrug
- poor outcomes when combined with other drugs
NNRTI MoA
inhibit RT allosterically by binding noncompetitively at a distinct site from NRTIs
notable ADME for NNRTI
all are metabolized by p450s so they are prone to drug interactions
NNRTI resistance
RT mutations